Mast Cells in Neuroimmune Interactions: Mechanisms, Pathophysiological Roles, and Therapeutic Implications
A systematic review was conducted on the role of mast cells in neuroimmune interactions and their implications in multiple sclerosis (MS) among other disorders. It discussed various dysfunctions and therapeutic approaches targeting mast cells.
- Most relevant to
- Neurologist, Immunologist
Why it matters
Understanding how mast cells interact in the nervous system could offer insights into their roles in MS and other neurodegenerative and psychiatric diseases, potentially guiding future therapeutic strategies.
What this does not prove
The review does not provide clinical trial data or specific research outcomes related to MS, limiting its applicability in predicting treatment effects.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-26
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceMast Cells and Their Role in Neuroimmune Interactions ↗
Supporting passages (5)
study designThis review presents a framework integrating MC differentiation with distinct CNS microenvironments to explain their neuroprotective and toxic roles.
findingsFurthermore, the roles in which mast cell dysfunction is implicated in neurodegenerative and psychiatric disorders are examined, including Alzheimer's disease (AD), where amyloid-β triggers MC degranulation, Parkinson's disease (PD), where α-synuclein induces MC activation, multiple sclerosis (MS), autism, anxiety, and depression, as well as peripheral neuroimmune conditions affecting the skin, gut-brain axis, and pain.
findingsCurrent and emerging mast cell-targeted therapies, including stabilizers, histamine receptor blockers, tryptase inhibitors, and anti-IgE biologics, are discussed, along with future challenges in mast cell-based neuroimmunological treatment.
publication datePublication date: 2026-09-26
limitationsTitle: Mast Cells in Neuroimmune Interactions: Mechanisms, Pathophysiological Roles, and Therapeutic Implications.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.